TrialOrphanet journal of rare diseases2012

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial.

Cristina Cabrera-López et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.